Technical Data
A0857-12A
APOA1BP (Apolipoprotein A-I-binding Protein, AI-BP, YjeF N-terminal Domain-containing Protein 1, YjeF_N1, AIBP, YJEFN1)
Description:
APOA1BP interacts with apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoproteins (HDLs). It is secreted into some bodily fluids, and its synthesis and secretion are stimulated in vitro by incubating cells with apoA-I.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 0.5-1.5ug/ml
Optimal dilutions to be determined by the researcher.

Positive Control:
Human Heart lysate

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanGoat
Concentration:
~0.5mg/ml
Immunogen:
Synthetic peptide corresponding to PPYPDTECVYRLQ, from the C-Terminus of the protein sequence according to NP_658985.2.
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a liquid in Tris saline, 0.02% sodium azide, pH7.3, 0.5% BSA.
Specificity:
Recognizes human APOA1BP. Species sequence homology: bovine, canine, mouse, rat, porcine.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.